We are live on ! Find out more
RBFC

Roman Butler Fullerton & Co Portfolio holdings

AUM $419M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+12.95%
1 Year Est. Return
+31.15%
3 Year Est. Return
+120.62%
5 Year Est. Return
+172.72%
10 Year Est. Return
AUM
$169M
AUM Growth
+$16.5M
Cap. Flow
+$390K
Cap. Flow %
0.23%
Top 10 Hldgs %
27.92%
Holding
180
New
27
Increased
90
Reduced
38
Closed
10

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.09M
2
T icon
AT&T
T
+$1.09M
3
CI icon
Cigna
CI
+$999K
4
ILCG icon
iShares Morningstar Growth ETF
ILCG
+$887K
5
BABA icon
Alibaba
BABA
+$830K

Sector Composition

Rank Sector Weight
1 Technology 24.03%
2 Communication Services 8.61%
3 Financials 8.25%
4 Consumer Staples 7.98%
5 Healthcare 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
51
Bristol-Myers Squibb
BMY
$130B
$1.09M 0.65%
17,634
+99
+0.6% +$6.09K
ASML icon
52
ASML
ASML
$691B
$1.08M 0.64%
2,224
+236
+12% +$99.3K
VOT icon
53
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.8B
$1.07M 0.63%
5,038
+37
+0.7% +$7.29K
EOS
54
Eaton Vance Enhance Equity Income Fund II
EOS
$1.18B
$1.06M 0.62%
48,749
+5,202
+12% +$103K
TGT icon
55
Target
TGT
$69.2B
$1.05M 0.62%
5,925
-112
-2% -$18.7K
PKW icon
56
Invesco BuyBack Achievers ETF
PKW
$1.77B
$1.04M 0.62%
14,220
+16
+0.1% +$1.06K
CVS icon
57
CVS Health
CVS
$120B
$1.01M 0.59%
14,750
+1,514
+11% +$98.5K
AOM icon
58
iShares Core Moderate Allocation ETF
AOM
$1.77B
$994K 0.59%
23,020
+2,502
+12% +$105K
AMD icon
59
Advanced Micro Devices
AMD
$774B
$988K 0.58%
10,773
+521
+5% +$45K
VRP icon
60
Invesco Variable Rate Preferred ETF
VRP
$3.01B
$985K 0.58%
37,959
-815
-2% -$20.6K
BUD icon
61
AB InBev
BUD
$159B
$909K 0.54%
13,006
+500
+4% +$31.6K
DGRO icon
62
iShares Core Dividend Growth ETF
DGRO
$43.7B
$893K 0.53%
19,922
+739
+4% +$31.4K
GLOB icon
63
Globant
GLOB
$1.68B
$878K 0.52%
4,037
+718
+22% +$139K
XYZ
64
Block Inc
XYZ
$47.5B
$861K 0.51%
3,957
-48
-1% -$9.36K
EMR icon
65
Emerson Electric
EMR
$91.7B
$851K 0.5%
10,590
+14
+0.1% +$1.04K
BAC icon
66
Bank of America
BAC
$448B
$845K 0.5%
27,887
+6,120
+28% +$164K
ENPH icon
67
Enphase Energy
ENPH
$5.59B
$840K 0.5%
4,788
+2,148
+81% +$272K
CTAS icon
68
Cintas
CTAS
$82.1B
$834K 0.49%
9,436
+4
+0% +$347
ADP icon
69
Automatic Data Processing
ADP
$108B
$817K 0.48%
4,635
ENTG icon
70
Entegris
ENTG
$23B
$812K 0.48%
+8,447
New +$738K
CAT icon
71
Caterpillar
CAT
$388B
$803K 0.47%
4,412
+386
+10% +$65.5K
MCD icon
72
McDonald's
MCD
$194B
$803K 0.47%
3,743
+206
+6% +$44.8K
CSCO icon
73
Cisco
CSCO
$475B
$781K 0.46%
17,463
-1,467
-8% -$60.3K
EPAM icon
74
EPAM Systems
EPAM
$5.15B
$758K 0.45%
2,115
+445
+27% +$149K
SR icon
75
Spire
SR
$4.87B
$708K 0.42%
11,059
+144
+1% +$8.78K

Similar funds

Roman Butler Fullerton & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Roman Butler Fullerton & Co held 180 positions worth $169M, up 11% from $153M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Roman Butler Fullerton & Co's Q4 2020 filing shows 27 new, 90 increased, 38 reduced and 10 closed positions. Its largest new stake was Entegris: 8,447 shares worth $812K. The largest sale was Vertex Pharmaceuticals, an estimated $1.09M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Communication Services and Financials.

  • Roman Butler Fullerton & Co's largest Q4 2020 buy was Entegris: 8,447 shares worth $812K.
  • Roman Butler Fullerton & Co added most to Apple in Q4 2020, an estimated $525K increase.
  • Roman Butler Fullerton & Co's biggest Q4 2020 reduction was AT&T, cutting an estimated $1.09M.
  • Roman Butler Fullerton & Co fully exited Vertex Pharmaceuticals in Q4 2020, selling an estimated $1.09M.
  • Roman Butler Fullerton & Co's ten largest holdings make up 28% of its $169M portfolio in Q4 2020.
  • Roman Butler Fullerton & Co opened 27 new positions and closed 10 in Q4 2020.
  • Roman Butler Fullerton & Co's portfolio value rose 11% quarter-over-quarter to $169M.

Based on Roman Butler Fullerton & Co's 13F filing for Q4 2020, filed 1 Feb 2021.